CTOs on the Move

NeuBase Therapeutics

www.neubasetherapeutics.com

 
NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington`s disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been “undruggable.” for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase`s pipeline includes
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Anthony Rossomando
 Chief Technology Officer Profile

Similar Companies

Verifique

Verifique is a company that provides fast and easy at-home test kits to detect unwanted substances in food, candies, powders, vape pens, edibles, pills, and powders. Their mission is to keep families and communities safe by creating easy-to-use narcoti...

Shenzhen Hepalink Pharmaceutical Co.

Hepalink was established in 1998 and restructured in 2007 to be a limited liability company.

Pharmaceutical Specialties Inc

Pharmaceutical Specialties Inc is a Bogart, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Harold Crossley

Harold Crossley is a Cockeysville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Syntonix Pharmaceuticals

Syntonix Pharmaceuticals, Inc is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.